Skila’s Simon Mason Rated Best Speaker at CBI Premier Bio/Pharmaceutical Forum

PRLog (Press Release) - Dec 01, 2008 -
The debut program for CBI showcased how pharmaceutical companies can develop effective systems that capture thought leader engagement information, ensure appropriate analysis, increase transparency and improve compliance across global functional departments. The conference attendees shared with CBI that Simon Mason was the #1 speaker with a “very relevant—on-topic presentation” that provided the audience with “very valuable insights” on today’s KOL-focused initiatives; why companies continuously miss the mark when it comes to KOL management; the implications of keeping status quo; and the critical success factors necessary to make these initiatives work.

“It was a pleasure to speak to such an engaging audience at the Bio/Pharmaceutical Forum on Integrated Opinion Leaser Management Systems,” says Simon Mason, COO, Skila.  “Establishing lasting and collaborative Relationships with Opinion Leaders is of critical importance for Pharmaceutical, Diagnostic, Biotech and Medical Device companies, and a great deal of resources are allocated to do so. This audience clearly understood the value and need for a sustainable, repeatable and transparent approach to the management of KOL relationships."

A copy of the presentation is available only to employees of Pharmaceutical, Diagnostic, Biotech and Medical Device companies and can be requested by sending an email to: marketing@skila.com

To find out more about the event, visit: http://www.cbinet.com/show_conference.cfm?confCode=PC08098

About Skila
Skila is a global technology and services company specializing in knowledge and effectiveness solutions for the healthcare industry. Skila’s solutions address the broad needs of global marketing, medical, executive and alliance management teams. These solutions include a unique methodology, robust technology and key continuous services for effectively managing key opinion leader relationships, global product launches, business performance, competitive intelligence, and key partnerships and alliances.

Having developed strong relationships with a broad number of global Pharmaceutical companies, Skila’s solutions have been deployed in 61 countries, supporting numerous global brands and over 10 million user interactions. Skila’s long-standing commitment and understanding of customers’ needs has resulted in the long-term growth and adoption of our methodology, technology and continuous services as the business platform of choice for many of our clients. To learn more about Skila visit our website at www.skila.com.